C
Chee H. Ng
Researcher at St. Vincent's Health System
Publications - 363
Citations - 10688
Chee H. Ng is an academic researcher from St. Vincent's Health System. The author has contributed to research in topics: Medicine & Mental health. The author has an hindex of 35, co-authored 313 publications receiving 6699 citations. Previous affiliations of Chee H. Ng include University of Melbourne & Harvard University.
Papers
More filters
Journal ArticleDOI
The psychiatric impact of COVID-19 on healthcare workers.
TL;DR: The aim of this article is to highlight the psychiatric impact of the COVID-19 pandemic on frontline HCWs, the need for screening and early diagnosis by general practitioners (GPs), and the appropriate psychosocial strategies and treatments to address this.
Journal ArticleDOI
Co-Morbid Obsessive-Compulsive Disorder and Attention Deficit Hyperactivity Disorder: Neurobiological Commonalities and Treatment Implications.
TL;DR: Cabarkapa S, King JA, Dowling N and Ng CH (2019) Co-Morbid Obsessive-Compulsive Disorder and Attention Deficit Hyperactivity Disorder: Neurobiological Commonalities and Treatment Implications.
Journal ArticleDOI
Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials.
Xiao Jing Gu,Rui Chen,Chen Hui Sun,Wei Zheng,Xin Hu Yang,Shi Bin Wang,Gabor S. Ungvari,Gabor S. Ungvari,Chee H. Ng,Andrei Golenkov,Grace K.I. Lok,Lu Li,Ines H.I. Chow,Fei Wang,Yu-Tao Xiang +14 more
TL;DR: Adjunctive ranitidine appears to be an effective and safe option for reducing antipsychotic-induced weight gain and improving negative symptoms in patients with schizophrenia.
Journal ArticleDOI
Psychomotor depressive symptoms may differentially respond to venlafaxine.
TL;DR: Predicting differential antidepressant efficacy remains an elusive goal in major depressive disorder (MDD), and possible preferential utility of a selective serotonin and noradrenaline reuptake inhibitor in cases of MDD presenting with greater psychomotor retardation is suggested.
Journal ArticleDOI
Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials:
Robson Zazula,Robson Zazula,Robson Zazula,Muhammad Ishrat Husain,Muhammad Ishrat Husain,Mohammadreza Mohebbi,Adam J. Walker,Imran B Chaudhry,Imran B Chaudhry,Ameer B. Khoso,Melanie M Ashton,Bruno Agustini,Nusrat Husain,J.F.W. Deakin,Allan H. Young,Allan H. Young,Michael Berk,Buranee Kanchanatawan,Chee H. Ng,Michael Maes,Michael Maes,Lesley Berk,Lesley Berk,Ajeet B. Singh,Gin S Malhi,Gin S Malhi,Olivia M Dean,Olivia M Dean +27 more
TL;DR: The improvement of depressive symptoms, anxiety severity and functional status is promising and suggests that minocycline has potential as an adjunctive treatment for major depressive disorder.